摘要
目的探讨布地奈德对变应性鼻炎嗅觉障碍的干预作用。方法选择来该院治疗的变应性鼻炎嗅觉障碍患者30例,患者在接受治疗前,通过T&T嗅觉检查及对嗅觉事件有关点位进行记录,评估嗅觉功能。之后予以布地奈德混悬液做鼻腔雾化吸入(1mg),治疗15d,1次/d。每治疗5次后,通过T&T嗅觉检查对嗅觉功能进行复查。在雾化吸入15次后对T&T的嗅觉识别阈及嗅觉事件有关点位进行同时复查。结果所选鼻炎嗅觉障碍患者在接受鼻腔雾化治疗后,8例(26.7%)患者恢复了正常的嗅觉功能,15例(50%)患者的嗅觉功能得到显著改善,5例(16.7%)患者的嗅觉功能得到轻微改善,2例患者治疗无效,总有效率为93.3%。结论布地奈德混悬液的鼻腔雾化吸入对治疗变应性鼻炎嗅觉障碍效果良好,此方法便捷、无创,且有较好的患者依从性,是临床较好的治疗方法。
Objective To observe the effect of budesonide on allergic rhinitis olfactory disorder. Methods To choose this paper from September 2009 to August 2011 to our treatment of allergic rhinitis dysosmia 30 cases patients, before treatment, through TT smell inspection and to smell event record relevant point, evaluating olfactory function. After be budesonide suspension （do） nasal spray suction （1 mg）, treatment of 15 days, one a day. Each treatment after 5 times, through TT smell the examination of the olfactory function for review. In the atomization inhalation after 15 times to TT olfactory recognition threshold and smell events related to review point at the same time. Results Patients undergoing nasal spray after treatment, 8 cases（26.7%） patients returned to normal olfactory function, 15 cases（50%）, the sense of smell function improved significantly in 5 patients（16.7%）, the patient＇s olfactory function get slight improvement, 2 patients treatment is invalid, the total effective rate was 93.3%. Conclusion Budesonide suspension of nasal atomization inhalation in the treatment of allergic rhinitis dysosmia effect is good, this method is convenient, noninvasive, and have good patients compliance, is the clinical good treatment.
出处
《中外医疗》
2013年第11期18-18,20,共2页
China & Foreign Medical Treatment
